These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 19393205

  • 1. Long term treatment of rheumatoid arthritis with rituximab.
    Caporali R, Caprioli M, Bobbio-Pallavicini F, Bugatti S, Montecucco C.
    Autoimmun Rev; 2009 Jun; 8(7):591-4. PubMed ID: 19393205
    [Abstract] [Full Text] [Related]

  • 2. [B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].
    Yukawa N, Mimori T.
    Clin Calcium; 2007 Apr; 17(4):569-76. PubMed ID: 17404487
    [Abstract] [Full Text] [Related]

  • 3. Long-term effects of rituximab in rheumatoid arthritis: clinical, biologic, and pharmacogenetic aspects.
    Quartuccio L, Lombardi S, Fabris M, Masolini P, Saracco M, Pellerito R, De Vita S.
    Ann N Y Acad Sci; 2009 Sep; 1173():692-700. PubMed ID: 19758217
    [Abstract] [Full Text] [Related]

  • 4. Rituximab for rheumatoid arthritis.
    Palylyk-Colwell E, McGahan L.
    Issues Emerg Health Technol; 2006 Sep; (89):1-4. PubMed ID: 17014062
    [Abstract] [Full Text] [Related]

  • 5. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F, Isenberg DA.
    Handb Exp Pharmacol; 2008 Sep; (181):163-81. PubMed ID: 18071946
    [Abstract] [Full Text] [Related]

  • 6. B cells in rheumatoid arthritis: from hypothesis to the clinic.
    Keystone EC.
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii8-ii12. PubMed ID: 15851525
    [Abstract] [Full Text] [Related]

  • 7. B cell-directed therapy in rheumatoid arthritis--clinical experience.
    Panayi GS.
    J Rheumatol Suppl; 2005 Feb; 73():19-24; discussion 29-30. PubMed ID: 15693112
    [Abstract] [Full Text] [Related]

  • 8. B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application.
    Mease PJ.
    J Rheumatol; 2008 Jul; 35(7):1245-55. PubMed ID: 18609733
    [Abstract] [Full Text] [Related]

  • 9. Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis.
    Roll P, Palanichamy A, Kneitz C, Dorner T, Tony HP.
    Arthritis Rheum; 2006 Aug; 54(8):2377-86. PubMed ID: 16869000
    [Abstract] [Full Text] [Related]

  • 10. Current aspects of anti-CD20 therapy in rheumatoid arthritis.
    Jacobi AM, Dörner T.
    Curr Opin Pharmacol; 2010 Jun; 10(3):316-21. PubMed ID: 20189875
    [Abstract] [Full Text] [Related]

  • 11. Rituximab treatment of refractory rheumatoid arthritis.
    Summers KM, Kockler DR.
    Ann Pharmacother; 2005 Dec; 39(12):2091-5. PubMed ID: 16249269
    [Abstract] [Full Text] [Related]

  • 12. [Targeting CD20 in rheumatoid arthritis].
    Saito K, Tanaka Y.
    Nihon Rinsho; 2007 Jul; 65(7):1243-9. PubMed ID: 17642239
    [Abstract] [Full Text] [Related]

  • 13. Anti-CD20 antibody rituximab in the treatment of rheumatoid arthritis.
    Korhonen R, Moilanen E.
    Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):13-21. PubMed ID: 19686542
    [Abstract] [Full Text] [Related]

  • 14. Treatment of rheumatoid arthritis with rituximab: an update and possible indications.
    De Vita S, Quartuccio L.
    Autoimmun Rev; 2006 Aug; 5(7):443-8. PubMed ID: 16920570
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
    Teng YK, Levarht EW, Hashemi M, Bajema IM, Toes RE, Huizinga TW, van Laar JM.
    Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
    [Abstract] [Full Text] [Related]

  • 16. Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs.
    Popa C, Leandro MJ, Cambridge G, Edwards JC.
    Rheumatology (Oxford); 2007 Apr; 46(4):626-30. PubMed ID: 17189244
    [Abstract] [Full Text] [Related]

  • 17. Panel discussion on B cells and rituximab: mechanistic aspects, efficacy and safety in rheumatoid arthritis and non-Hodgkin's lymphoma.
    Panayi GS, Hainsworth JD, Looney RJ, Keystone EC.
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii18-ii20. PubMed ID: 15851523
    [Abstract] [Full Text] [Related]

  • 18. What is the role of rituximab in the treatment of rheumatoid arthritis?
    Atzeni F, Doria A, Turiel M, Sarzi-Puttini P.
    Autoimmun Rev; 2007 Sep; 6(8):553-8. PubMed ID: 17854748
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic B cell depletion and regeneration in rheumatoid arthritis: emerging patterns and paradigms.
    Silverman GJ.
    Arthritis Rheum; 2006 Aug; 54(8):2356-67. PubMed ID: 16868991
    [No Abstract] [Full Text] [Related]

  • 20. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R, Albert D.
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.